4258-K ·Filed Jul 23, 2026

THRM

Gentherm Inc
BULLISH
Impact 6/10
Horizonweeks Processed2mo ago SEC0001193125-26-313208
Actionable Insight ▲ Bullish

The combination of record revenue, raised guidance, and a $400M buyback authorization (36% of market cap) is a strong bullish signal. However, the sharp decline in GAAP operating income and operating cash flow due to restructuring/M&A costs warrants monitoring for normalization in H2. The Modine deal closing in early Q4 is the next major catalyst — watch for S-4 effectiveness and shareholder vote.

DirectionBullish
Confidencehigh
Horizonweeks
Latest settled — T+20d ⚠ clustered
THRM ▼ -10.81% at T+20d
LONG call ✗ call lost -10.81% · α vs SPY -14.12% · entry $45.61 → $40.68
Next anchor: T+60d in 14d
Latest observation: T+47 -30.02% FF3 residual α
Entry anchored
Jul 22, 03:59 PM ET
via exchange tick
T+1d
-6.40%
call -6.40% · α -6.50%
$42.69
settled 2mo ago
T+5d
-7.21%
call -7.21% · α -7.69%
$42.32
settled 2mo ago
T+20d
-10.81%
call -10.81% · α -14.12%
$40.68
settled 6w ago
T+60d
—
call — · α —
—
in 14d

Price Chart

Loading chart...

Executive Summary

Gentherm reported record Q2 2026 revenue of $416.2M, up 11.0% YoY (9.5% ex-FX), and raised full-year 2026 guidance for revenue, Adjusted EBITDA, and free cash flow. The Board also authorized a new $400M stock repurchase program, replacing the prior $150M program. The company completed the acquisition of Innovative Medical Equipment, LLC and confirmed the Modine Performance Technologies combination remains on track for early Q4 2026. However, GAAP operating income declined sharply to $10.7M from $24.0M due to elevated restructuring and M&A expenses, and operating cash flow fell to $2.3M from $31.7M, tempering the headline revenue beat.

Key Facts

  • Record quarterly product revenue of $416.2M, up 11.0% YoY (9.5% ex-FX)
  • Full-year 2026 guidance raised: revenue to $1.55B-$1.65B (from $1.5B-$1.6B), Adjusted EBITDA to $185M-$200M (from $175M-$195M)
  • Board authorized new $400M stock repurchase program (3-year term), replacing prior $150M program with $110.1M remaining
  • Adjusted diluted EPS of $0.75 vs $0.54 YoY; GAAP diluted EPS $0.14 vs $0.02 YoY
  • GAAP operating income fell to $10.7M from $24.0M; operating cash flow dropped to $2.3M from $31.7M
  • Acquired Innovative Medical Equipment, LLC (ThermaZone device); Modine Performance Technologies deal on track for early Q4 2026
  • Net leverage of ~0.3x; liquidity of $502.3M; cash and equivalents $213.2M

Financial Impact

Record quarterly revenue of $416.2M (+11% YoY); Adjusted EBITDA $48.8M (11.7% margin); GAAP net income $4.4M vs $0.5M; raised FY guidance midpoint by $75M revenue and $7.5M EBITDA

revenueadjustedEbitdaadjustedEpsoperatingCashFlowshareRepurchaseAuthorization

Risk Factors

  • GAAP operating income declined 55% YoY due to $12.9M M&A and $6.0M restructuring costs
  • Operating cash flow fell to $2.3M from $31.7M; free cash flow was negative $11.9M YTD
  • Modine Performance Technologies deal integration risk and potential shareholder approval delays
  • Automotive production in relevant markets expected to decline at low single-digit rate in 2026
  • Gross margin contracted 70bps YoY to 23.2% due to higher material costs and warranty accruals

Market Snapshot

Exchange
Nasdaq
Sector
Motor Vehicle Parts & Accessories
Analyst Consensus
71% bullish (14 analysts)

Investment Themes

Industrials & Manufacturing

Documents Analyzed

This report is based on 9 SEC documents filed with EDGAR.

DocumentAccession Number
425 Filing (THRM) — Batch item 10001193125-26-313208
Document: 0001193125-26-313208-index-headers.html0001193125-26-313204
Document: 0001193125-26-313208-index.html0001193125-26-313208
Document: 0001193125-26-313208.txt0001193125-26-313208
8-K Filing (THRM) — Batch item 50001193125-26-313204
Document: thrm-20260723.htm0001193125-26-313208
Document: 0001193125-26-313204-index-headers.html0001193125-26-313208
Document: 0001193125-26-313204-index.html0001193125-26-313208
Document: 0001193125-26-313204.txt0001193125-26-313208
18 reports for THRM
Performance horizon
78% Hit rate 7 of 9 directional calls best @ T+20▲ +20.85%Jul 7, 2026
Filters
Rows
Reports for THRM — sortable, filterable
TypeNow
Sep 11, 2026
21d ago
8-K
BULLISH ★ 6/10
$38.85 $36.35▼ −6.43%▼ −6.21%$31.30 (−19.43%)
Sep 10, 2026
22d ago
Press Release
BULLISH ★ 7/10
$38.33 $37.66▼ −1.75%▼ −1.25%$31.30 (−18.34%)
Aug 13, 2026
7w ago
EFFECT
NEUTRAL ★ 3/10
$43.07 $40.67▼ −5.57%▼ −3.61%$31.30 (−27.33%)
Jul 23, 2026
10w ago
425 / 8-K
BULLISH ★ 6/10
$45.61 $42.32▼ −7.21%▼ −7.69%$31.30 (−31.37%)
Jul 23, 2026
10w ago
Press Release
BULLISH ★ 7/10
$45.61 $42.32▼ −7.21%▼ −7.69%$31.30 (−31.37%)
Jul 22, 2026
10w ago
Press Release
NEUTRAL ★ 3/10
$45.61 $42.32▼ −7.21%▼ −7.69%$31.30 (−31.37%)
Jul 20, 2026
10w ago
Press Release
BULLISH ★ 6/10
$36.64 $42.07▲ +14.82%▲ +16.05%$31.30 (−14.57%)
Jul 7, 2026
12w ago
Press Release
BULLISH ★ 6/10
$34.48 $35.89▲ +4.09%▲ +3.23%$31.30 (−9.22%)
Jul 2, 2026
13w ago
425
NEUTRAL ★ 5/10
$33.88 $35.68▲ +5.31%▲ +4.38%$31.30 (−7.62%)
Jul 2, 2026
13w ago
8-K
NEUTRAL ★ 3/10
$33.88 $35.68▲ +5.31%▲ +4.38%$31.30 (−7.62%)
Showing 10 of 18

US Market Status

Market Closed — Opens Mon (37h 46m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access